WELLS FARGO Q4 EARNINGS UPDATE
Go Digit Q4 Results: PAT jumps 104% YoY to Rs 53 crore; gross written premium up 19%
The net profit stood at Rs 182 crore for the full financial year as against Rs 36 crore in FY23, recording a 405% jump. The gross written premium for the full financial year stood at 9,016 crore versus Rs 7,243 crore in FY23.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Tata Steel Q4 Results: Net profit slumps 64% YoY to Rs 611 crore; misses D-St estimates
Tata Steel Q4 Results: Revenue from operations for the quarter under review fell 7% YoY to Rs 58,687 crore. The company's board has recommended a dividend of Rs 3.6 per share. It has also approved a proposal to infuse funds up to $2.11 billion (Rs 17,407.50 crore), by way of subscription to equity shares of T Steel Holdings Pte Ltd in one or more tranches during FY25.
Mazagon Dock Q4 Results: PAT skyrockets 103% YoY to Rs 663 crore, revenue jumps 49%
On a sequential basis, the PAT was higher by 5.7%. The consolidated revenue from operations stood at Rs 3,104 crore in the reported quarter. It was Rs 2,079 crore in the year-ago period. The government-owned shipbuilding company declared a final dividend of Rs 12.11 per share for the year ended March 31.
IRCTC Q4 Results: Cons PAT rises marginally to Rs 284 crore, but revenue jumps 20% YoY
IRCTC Q4 Results: The PAT was reported at Rs 278 crore in the year-ago period. The consolidated revenue from operations for the reported quarter stood at Rs 1,155 crore as against Rs 965 crore reported in the year-ago period. The consolidated net profit was, however, down on a sequential basis by 5% versus Rs 300 crore.
- Go To Page 1
LIC Q4 Results: Cons PAT jumps 4.5% YoY to Rs 13,782 cr; dividend declared at Rs 6 per share
LIC Q4 Results: The company had reported a net profit of Rs 13,191 crore in the corresponding period of the last financial year. The Total Premium Income for the year ended March 31, 2024, was reported at Rs 4,75,070 crore. It was Rs 4,74,005 crore for the year ended March 31 2023. The Total Individual Business Premium for the financial year increased to Rs 3,03,768 crore from Rs 2,92,763 crore reported for the comparable period of the previous year.
Divi's Laboratories Q4 Results: Cons PAT soars 68% YoY to Rs 538 crore; dividend declared at Rs 30 per share
Divi's Laboratories Q4 Results: Net profit stood at Rs 321 crore in the corresponding quarter of the last financial year. The consolidated revenue in Q4 FY24 jumped 18% YoY to Rs 2,303 crore from Rs 1,951 crore reported in Q4 FY23. For the full financial year FY24, the consolidated profit after tax was reported at Rs 1,600 crore, a considerable drop from Rs 1,824 crore reported in FY23.
Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY
Glenmark Pharma Q4 Results: The rise in loss was on account of declining sales in the US and exceptional items. It had reported a net loss of Rs 34.5 crore in the corresponding quarter of the previous year. In FY24, Glenmark's consolidated revenue reached Rs. 11,813 crore, a 2% increase year-over-year. The company's EBITDA margin for the fiscal year was 10.1%, primarily due to a one-time impact on sales in the India business during the third quarter.
Karnataka Bank Q4 Results: Net profits dips 23% YoY to Rs 274 crore, dividend declared at Rs 5.5 per share
Its net interest margin, a key profitability metric, fell 57 basis points to 3.3% for the quarter as compared with 3.87% seen in the year-ago period. Net interest income was 3% lower at Rs 834 crore.
Ashok Leyland Q4 Results: Net profit jumps 20% to Rs 900.41 crore
Revenues from operations in the quarter under review stood at Rs 11,266.69 crore as compared to Rs 11,625.67 crore in the year-ago period.
Hudco Q4 Results:Net profit rises 9% YoY to Rs 700 crore
The company's total income for the quarter was 18% higher at Rs 2,194 crore against Rs 1,862 crore. Its board recommended a final dividend of Rs 2.65 per equity share on the face value of Rs10 each for the financial year 2023-24.
ICRA Q4 Results: Net profit jumps 22% YoY to Rs 47 crore
Its firm growth in the core rating business drove the firm’s performance amid healthy demand for credit in the economy. Sequentially, the firm’s net profit registered a sharper increase, rising 45% from Rs 32.41 crore in the October-December quarter.
Puravankara Q4 Results: Loss narrows to Rs 7 crore YoY; revenue shoots up 112% YoY
The firm has launched 12 projects with a saleable area of 9.47 million square feet, reinforcing its expansion into high- potential micro-markets for the fourth quarter (Q4FY24) ending March 31, 2024.
ITC Q4 Results: Net profit drops marginally to Rs 5,020 crore
Revenue from operations went up by 1.4% at Rs 17,752.87 crore in the period under review. The company said excluding the agri-business (which was severely impacted due to government restrictions in trade of agri-commodities), the company’s gross revenue during the fourth quarter has gone up by 6% y-o-y.
Grasim Q4 Results: Net profit jumps 39% YoY to Rs 1,908 crore; revenue rises 13%
Grasim Q4 Results: The net profit stood at Rs 1,369 crore in the last year quarter. Revenue from operations increased 13% year-on-year to Rs 37,727 crore in the reporting period, compared with Rs 4,873 crore in the corresponding period of previous year.
Gland Pharma Q4 Results: Net profit more than doubles to Rs 192.4 crore
The company declared its first-ever post-listing dividend of Rs 20 per equity share for FY24.
Nykaa Q4 Results: Profit zooms 187% YoY to Rs 6.9 crore; revenue rises 28%
Nykaa Q4 Results: The consolidated net profit stood at Rs 2.4 crore in the last-year period. The company's board has approved an investment of Rs 20 crore in FSN International, a wholly-owned subsidiary, on a rights basis.
Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates
Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
The Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4FY 24 grew by 37% YoY to Rs 551 crore. The net debt on March 31 stood at Rs 2700 crore.
Metropolis Healthcare Q4 Results: Net profit rises 8% to Rs 36 crore
The diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 11% YoY to Rs 313 crore.
TV Today Network Q4 Results: Net profit jumps nearly 2-fold to Rs 11.46 crore
The company had posted a consolidated net profit of Rs 5.85 crore in the year-ago period, TV Today Network said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 252.79 crore against Rs 217.14 crore in the corresponding period a year ago.
Bandhan Bank Q4 Results: Net profit slumps 93% YoY to Rs 55 crore
Sharply higher provisioning dragged Bandhan Bank's March quarter net profit down by 93% at Rs 55 crore against Rs 808 crore in the year-ago period.
ZEEL Q4 Results: Company reports profit of Rs 13 crore versus loss YoY; revenue rises 3%
ZEEL Q4 Results: The company reported a loss of Rs 196 crore in the same quarter last year. The revenue from operations for the quarter stood at Rs 2,185 core against Rs 2,126 crore in the corresponding quarter of the previous year.
Biocon Q4 Results: Net profit drops 57% to Rs 136 crore
Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an EBITDA margin of 24% versus 29% in the same period last year. The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24.
Motherson Sumi Wiring Q4 Results: PAT jumps 38% YoY to Rs 191 crore, revenue rises 19%
Motherson Sumi Wiring Q4 Results: The company’s revenue for the period was reported at Rs 2,233 cr, a 19% jump YoY. The board has announced a dividend of Rs 0.80 per share.
Vodafone Idea Q4 Results: Cons loss widens to Rs 7,675 crore YoY; ARPU rises to Rs 146 from Rs 135
Vodafone Idea Q4 Results: Revenue from operations stood at Rs 10,607 crore against Rs 10,532 crore reported in the corresponding quarter of the last financial year. Its EBITDA for the quarter was reported at Rs 4,336 crore and there was an increase in subscriber base to 12.63 crore versus 12.26 crore in Q4FY23.
Karur Vysya Bank Q4 Results: Net profit jumps 35% YoY to Rs 456 crore
The bank's net interest income for the quarter improved 11.5% to Rs 996 crore while other income was 57% higher at Rs 629 crore. The net interest margin for the quarter, however, was at 4.19%, down 18 basis points from 4.37% a year ago.
Jindal Steel Q4 Results: Cons PAT zooms 100% YoY to Rs 933 crore, but revenue falls 1%
Jindal Steel Q4 Results: In the corresponding quarter of the last financial year, the company reported a PAT of Rs 466 crore. On a sequential basis, the consolidated PAT was down 52% versus Rs 1,928 crore reported in Q3FY24. Gross revenue for the quarter under review stood at Rs 15,749 crore, down from Rs 15,797 crore reported in Q4FY23.
Load More